Monoklonalní gamapatie nejasného významu s nízkým a vysokým stupněm rizika: výstupy z analýz RMG registru České myelomové skupiny pro praxi

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Monoclonal gammopathy of undetermined significance with low and high risk degree: outputs from analyses RMG of register of Czech myeloma group for practice
Authors

SANDECKÁ V. HÁJEK R. ADAM Zdeněk ŠPIČKA I. ŠČUDLA V. GREGORA E. RADOCHA J. WALTEROVÁ L. KESSLER P. ADAMOVÁ D. VALENTOVÁ K. VONKE I. ULMANOVÁ L. STAROSTKA D. WRÓBEL M. BROŽOVÁ Lucie JARKOVSKÝ Jiří MIKULÁŠOVÁ Aneta ŘÍHOVÁ L. ALMÁŠI Martina ŠEVČÍKOVÁ Sabina KREJČÍ Marta STRAUB J. MINAŘÍK J. PAVLÍČEK P. POUR Luděk VŠIANSKÁ Pavla OKUBOTE Samuel Adeyinka PENKA Miroslav MAISNAR V.

Year of publication 2015
Type Article in Periodical
Magazine / Source Klinická biochemie a metabolismus
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords multiple myeloma; monoclonal gammopathy of undetermined signifikance; risk factors
Description Results: 1887 MGUS persons were followed with median 4 years. Malignancies developed in 8.6 % (162/1887) cases; MM occurred in 77.2 % (125/162) of persons. The risk of progression was 1.5 % at 1 year, 7.6 % at 5 years and 16.5 % at 10 years after diagnosis.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.